Michal Schwartz-Eisenbach,Matityahu Fridkin,Michal Cardon-Yaakov
申请号：
US15180031
公开号：
US10072044B2
申请日:
2016.06.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present application provides synthetic modified peptides of five to seven natural or non-natural amino acids as well as pharmaceutical compositions comprising them, for use in the treatment a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, depression or cognitive impairment, particularly schizophrenia and Alzheimers disease.
